BeiGene Statistics
Share Statistics
BeiGene has 7.64M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 7.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,931 |
| FTD / Avg. Volume | 1.02% |
Short Selling Information
The latest short interest is 2.03M, so 1.88% of the outstanding
shares have been sold short.
| Short Interest | 2.03M |
| Short % of Shares Out | 1.88% |
| Short % of Float | 2.7% |
| Short Ratio (days to cover) | 4.53 |
Valuation Ratios
The PE ratio is -2.32 and the forward
PE ratio is 36.73.
BeiGene's PEG ratio is
0.
| PE Ratio | -2.32 |
| Forward PE | 36.73 |
| PS Ratio | 0.39 |
| Forward PS | 0.3 |
| PB Ratio | 0.45 |
| P/FCF Ratio | -2.23 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for BeiGene.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.8,
with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.8 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -2.72 |
| Debt / FCF | -1.61 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $346,385.55 |
| Profits Per Employee | $-58,616.91 |
| Employee Count | 11,000 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.2 |
Taxes
| Income Tax | 111.78M |
| Effective Tax Rate | -20.97% |
Stock Price Statistics
The stock price has increased by 68.04% in the
last 52 weeks. The beta is 0.29, so BeiGene's
price volatility has been higher than the market average.
| Beta | 0.29 |
| 52-Week Price Change | 68.04% |
| 50-Day Moving Average | 242.15 |
| 200-Day Moving Average | 219.8 |
| Relative Strength Index (RSI) | 55.47 |
| Average Volume (20 Days) | 484,114 |
Income Statement
In the last 12 months, BeiGene had revenue of 3.81B
and earned -644.79M
in profits. Earnings per share was -79.43.
| Revenue | 3.81B |
| Gross Profit | 3.22B |
| Operating Income | -568.2M |
| Net Income | -644.79M |
| EBITDA | -396.44M |
| EBIT | -568.2M |
| Earnings Per Share (EPS) | -79.43 |
Full Income StatementBalance Sheet
The company has 2.63B in cash and 1.08B in
debt, giving a net cash position of 1.55B.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 1.08B |
| Net Cash | 1.55B |
| Retained Earnings | -8.61B |
| Total Assets | 5.84B |
| Working Capital | 1.91B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -140.63M
and capital expenditures -529.14M, giving a free cash flow of -669.77M.
| Operating Cash Flow | -140.63M |
| Capital Expenditures | -529.14M |
| Free Cash Flow | -669.77M |
| FCF Per Share | -6.36 |
Full Cash Flow StatementMargins
Gross margin is 84.41%, with operating and profit margins of -14.91% and -16.92%.
| Gross Margin | 84.41% |
| Operating Margin | -14.91% |
| Pretax Margin | -13.99% |
| Profit Margin | -16.92% |
| EBITDA Margin | -10.4% |
| EBIT Margin | -14.91% |
| FCF Margin | -17.58% |
